Effective therapy for clinically significant fibrosis in non-alcoholic fatty liver disease (NAFLD) is an unmet need. Data on the effectiveness of endoscopic placement of intragastric balloon (IGB) in patients with NAFLD are limited. In this study, we evaluated the impact of IGB placement in NAFLD patients with advanced fibrosis.

Effects Of Intragastric Balloon In Patients With Non-Alcoholic Fatty Liver Disease And Advanced Fibrosis

Currenti, Walter;Galvano, Fabio
2021-01-01

Abstract

Effective therapy for clinically significant fibrosis in non-alcoholic fatty liver disease (NAFLD) is an unmet need. Data on the effectiveness of endoscopic placement of intragastric balloon (IGB) in patients with NAFLD are limited. In this study, we evaluated the impact of IGB placement in NAFLD patients with advanced fibrosis.
2021
Intragastric balloon
NAFLD
liver stiffness
obesity
weight loss
File in questo prodotto:
File Dimensione Formato  
Effects of intragastric balloon.pdf

solo gestori archivio

Tipologia: Versione Editoriale (PDF)
Dimensione 374.26 kB
Formato Adobe PDF
374.26 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/508268
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact